Worldwide, pediatric uveitis (PU) are rare diseases involving 3/100.000 children and are the second cause of blindness. PU can be isolated or associated with overt or hidden systemic diseases including juvenile idiopathic arthritis, other inflammatory or auto-immune diseases, and infectious diseases. ...
Worldwide, pediatric uveitis (PU) are rare diseases involving 3/100.000 children and are the second cause of blindness. PU can be isolated or associated with overt or hidden systemic diseases including juvenile idiopathic arthritis, other inflammatory or auto-immune diseases, and infectious diseases. Pediatric specificities of uveitis include a more complex diagnostic and therapeutic approach. Finally, important disparities exist regarding the epidemiology, the management and the prognosis of PU between countries with low/middle-income countries and high-income ones.
The current challenges regarding PU are related to:
- A better understanding of their pathophysiology;
- Ways to reduce diagnosis delays;
- The optimal diagnosis work-up;
- The benefit-risk balance of therapeutic options;
- The long-term outcome in adulthood.
This Research Topic will welcome contributions related to any of these challenges.
Keywords:
pediatric, uveitis, blindness, inflammatory, auto-immune
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.